2,6-Bis[(4S,5S)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl]pyridine, 97%, 1g

N-(4-methylbenzyl)-3-oxobutanamide, 95.0%, 1g

3-Bromo-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

N-methyl-2-butanamine hydrochloride, 95.0%, 1g

4-N-(2-Aminoethyl)-1-N-Boc-piperazine, 98.0%, 5g

Tricholine Citrate (ca. 65% in Water)25g

1-(3-(5-Oxo-1-phenyl-2-thioxoimidazolidin-4-yl)propyl)guanidine hydrochloride, 98%, 25mg

2-Amino-2-(2-methoxyphenyl)ethanol, 95.0%, 1g

2-amino-3-(methylsulfanyl)propanoic acid, 95.0%, 25g

4-(((3-methylphenyl)sulfonamido)methyl)benzoic acid, 95.0%, 250mg

HPLC-Anschlusskappen GL 45, 2 Anschlüsse, f. Schläuche Ø innen x außen 1,6 x 3,2mm, Durchgangsbohrung 1,6 mm, 1 Stück

1-O-tert-Butyl 6-O-methyl 3,4-dihydro-2H-1,5-naphthyridine-1,6-dicarboxylate, 95+%, 250mg

1-Boc-2-Methoxypyrrolidine, 95.0%, 100mg